Hormone therapy and psychosocial factors in menopausal women with painful TMD: a pilot cross-sectional study

Authors

  • Lays Nóbrega Gomes Farias Universidade Federal da Paraíba. Departamento de Clínica e Odontologia Social.
  • Raimundo Euzébio da Costa Neto Universidade Federal da Paraíba. Departamento de Clínica e Odontologia Social.
  • Mayara Abreu Pinheiro Universidade Federal da Paraíba. Departamento de Clínica e Odontologia Social.
  • Yuri Wanderley Cavalcanti lUniversidade Federal da Paraíba. Departamento de Clínica e Odontologia Social.

DOI:

https://doi.org/10.1590/

Keywords:

Menopause., Temporomandibular joint dysfunction syndrome, Psychosocial effects of the disease

Abstract

Introduction:  Temporomandibular Disorder (TMD) is a musculoskeletal condition prevalent in women, especially during menopause. This phase of life is marked by decreased estrogen levels, which can exacerbate pain and psychosocial symptoms. Objective:  This study aimed to evaluate the association between menopause with and without hormone replacement therapy, grade of chronic pain, jaw functional limitations, and symptoms of anxiety and depression in women with painful TMD. Methodology:  This exploratory cross-sectional study was conducted with 45 women diagnosed with painful TMD, divided into three groups: women with regular menstrual cycles (RMC, n=15), women in menopause without hormone replacement therapy (M, n=14), and women in menopause with hormone replacement therapy (MWH, n=16). The evaluation was conducted using the following instruments: the Graded Chronic Pain Scale (GCPS-2), the Patient Health Questionnaire (PHQ-9), the Generalized Anxiety Disorder Scale (GAD-7), the Jaw Functional Limitation Scale (JFLS-8), and the Pain Catastrophizing Scale (B-PCS). The data were analyzed descriptively using Jamovi software (version 2.3.21). Analysis of variance (ANOVA) was performed, followed by multivariate analysis of covariance (MANOVA). Tukey's post-hoc test was used to identify differences between groups. The significance level adopted for all analyses was 5%. Results:  The mean age of participants was 50.0 years (±13.7). The overlap between muscle and joint disorders was most prevalent among the groups. The interference score was significantly lower in the MWH group (p=0.003), as was also the case with depressive symptoms (p<0.001) and anxious symptoms (p=0.012). Conclusion:  The findings highlight the association between menopause, especially with hormone replacement therapy, and emotional and psychosocial aspects related to pain, with lower scores for interference with daily activities, depression, anxiety, and fewer catastrophic thoughts about pain.

Downloads

Download data is not yet available.

References

1- American Academy of Orofacial Pain. Orofacial pain: guidelines for assessment, diagnosis, and management. 6th ed. Chicago: Quintessence Publishing Co, Inc.; 2018.

2- List T, Jensen RH. Temporomandibular disorders: old ideas and new concepts. Cephalalgia. 2017;37(7):692–704. doi: 10.1177/0333102416686302

» https://doi.org/10.1177/0333102416686302

3- Kapos FP, Exposto FG, Oyarzo JF, Durham J. Temporomandibular disorders: a review of current concepts in aetiology, diagnosis and management. Oral Surg. 2020;13(4):321–34. doi: 10.1111/ors.12473

» https://doi.org/10.1111/ors.12473

4- Slade GD, Diatchenko L, Bhalang K, Sigurdsson A, Fillingim RB, Belfer I, et al. Influence of psychological factors on risk of temporomandibular disorders. J Dent Res. 2007;86(11):1120–5. doi: 10.1177/154405910708601119

» https://doi.org/10.1177/154405910708601119

5- Yap AU, Marpaung C. Personality, psychosocial and oral behavioural risk factors for temporomandibular disorder symptoms in Asian young adults. J Oral Rehabil. 2023;50(10):931–9. doi: 10.1111/joor.13527

» https://doi.org/10.1111/joor.13527

6- Staniszewski K, Ronold EH, Hammar Å, Rosén A. Neurocognitive functioning in patients with painful temporomandibular disorders. J Pain Res. 2023;16:2015–25. doi: 10.2147/JPR.S414922

» https://doi.org/10.2147/JPR.S414922

7- Bueno CH, Pereira DD, Pattussi MP, Grossi PK, Grossi ML. Gender differences in temporomandibular disorders in adult populational studies: a systematic review and meta-analysis. J Oral Rehabil. 2018;45(9):720–9. doi: 10.1111/joor.12661

» https://doi.org/10.1111/joor.12661

8- Farzin M, Taghva M, Babooie M. Comparison of temporomandibular disorders between menopausal and non-menopausal women. J Korean Assoc Oral Maxillofac Surg. 2018;44(5):232–6. doi: 10.5125/jkaoms.2018.44.5.232

» https://doi.org/10.5125/jkaoms.2018.44.5.232

9- Craft RM. Modulation of pain by estrogens. Pain. 2007;132(Suppl 1):S3–12. doi: 10.1016/j.pain.2007.09.028

» https://doi.org/10.1016/j.pain.2007.09.028

10- Paredes S, Cantillo S, Candido KD, Knezevic NN. An association of serotonin with pain disorders and its modulation by estrogens. Int J Mol Sci. 2019;20(22):5729. doi: 10.3390/ijms20225729

» https://doi.org/10.3390/ijms20225729

11- Fenzi F, Rizzuto N. Estrogen receptors localization in the spinal trigeminal nucleus: an immunohistochemical study in humans. Eur J Pain. 2011;15(10):1002–7. doi: 10.1016/j.ejpain.2011.05.003

» https://doi.org/10.1016/j.ejpain.2011.05.003

12- Panevin TS, Bobkova AO, Karateev AE, Zotkin EG. Endogenous estrogen deficiency and the development of chronic musculoskeletal pain: a review. Ter Arkh. 2022;94(5):683–8. doi: 10.26442/00403660.2022.05.201490

» https://doi.org/10.26442/00403660.2022.05.201490

13- Lee DY, Andreescu C, Aizenstein H, Karim H, Mizuno A, Kolobaric A, et al. Impact of symptomatic menopausal transition on the occurrence of depression, anxiety, and sleep disorders: a real-world multi-site study. Eur Psychiatry. 2023;66(1):e80. doi: 10.1192/j.eurpsy.2023.2439

» https://doi.org/10.1192/j.eurpsy.2023.2439

14- Alblooshi S, Taylor M, Gill N. Does menopause elevate the risk for developing depression and anxiety? Results from a systematic review. Australas Psychiatry. 2023;31(2):165–73. doi: 10.1177/10398562231165439

» https://doi.org/10.1177/10398562231165439

15- Juang KD, Wang SJ, Lu SR, Lee SJ, Fuh JL. Hot flashes are associated with psychological symptoms of anxiety and depression in peri- and post- but not premenopausal women. Maturitas. 2005;52(2):119–26. doi: 10.1016/j.maturitas.2005.01.005

» https://doi.org/10.1016/j.maturitas.2005.01.005

16- Mulhall S, Andel R, Anstey KJ. Variation in symptoms of depression and anxiety in midlife women by menopausal status. Maturitas. 2018;108:7–12. doi: 10.1016/j.maturitas.2017.11.005

» https://doi.org/10.1016/j.maturitas.2017.11.005

17- Tang RY, Luo M, Fan YB, Xie LZ, Huang FL, Zhang DD, et al. Effects of menopause on depressive and anxiety symptoms in community women in Beijing. Zhonghua Fu Chan Ke Za Zhi. 2022;57(6):419–25. doi: 10.3760/cma.j.cn112141-20220208-00064

» https://doi.org/10.3760/cma.j.cn112141-20220208-00064

18- Lin MF, Ko HC, Wu JY, Chang FM. The impact of extroversion or menopause status on depressive symptoms among climacteric women in Taiwan: neuroticism as moderator or mediator? Menopause. 2008;15(1):138–43. doi: 10.1097/gme.0b013e31804b419d

» https://doi.org/10.1097/gme.0b013e31804b419d

19- Petrini L, Arendt-Nielsen L. Understanding pain catastrophizing: putting pieces together. Front Psychol. 2020;11:603420. doi: 10.3389/fpsyg.2020.603420

» https://doi.org/10.3389/fpsyg.2020.603420

20- Goodin BR, McGuire L, Allshouse M, Stapleton L, Haythornthwaite JA, Burns N, et al. Associations between catastrophizing and endogenous pain-inhibitory processes: sex differences. J Pain. 2009;10(2):180–90. doi: 10.1016/j.jpain.2008.08.012

» https://doi.org/10.1016/j.jpain.2008.08.012

21- Nyitrai E, Takács S. Psychological factors influencing the experience of menstrual pain: the role of pain catastrophizing. Orv Hetil. 2023;164(37):1469–75. doi: 10.1556/650.2023.32857

» https://doi.org/10.1556/650.2023.32857

22- McPeak AE, Allaire C, Williams C, Albert A, Lisonkova S, Yong PJ. Pain catastrophizing and pain health-related quality of life in endometriosis. Clin J Pain. 2018;34(4):349–56. doi: 10.1097/AJP.0000000000000539

» https://doi.org/10.1097/AJP.0000000000000539

23- Hilgenberg-Sydney PB, Kowacs PA, Conti PC. Somatosensory evaluation in dysfunctional syndrome patients. J Oral Rehabil. 2016;43(2):89–95. doi: 10.1111/joor.12344

» https://doi.org/10.1111/joor.12344

24- Proença JD, Baad-Hansen L, Braido GV, Mercante FG, Campi LB, Gonçalves DA. Lack of correlation between central sensitization inventory and psychophysical measures of central sensitization in individuals with painful temporomandibular disorder. Arch Oral Biol. 2021;124:105063. doi: 10.1016/j.archoralbio.2021.105063

» https://doi.org/10.1016/j.archoralbio.2021.105063

25- Schiffman E, Ohrbach R, Truelove E, Look J, Anderson G, Goulet JP, et al. Diagnostic criteria for temporomandibular disorders (DC/TMD) for clinical and research applications: recommendations of the International RDC/TMD Consortium Network and Orofacial Pain Special Interest Group. J Oral Facial Pain Headache. 2014;28(1):6–27. doi: 10.11607/jop.1151

» https://doi.org/10.11607/jop.1151

26- Schiffman E, Ohrbach R. Executive summary of the Diagnostic Criteria for Temporomandibular Disorders for clinical and research applications. J Am Dent Assoc. 2016;147(6):438–45. doi: 10.1016/j.adaj.2016.01.007

» https://doi.org/10.1016/j.adaj.2016.01.007

27- Von Korff M, Ormel J, Keefe FJ, Dworkin SF. Grading the severity of chronic pain. Pain. 1992;50(2):133–49. doi: 10.1016/0304-3959(92)90154-4

» https://doi.org/10.1016/0304-3959(92)90154-4

28- Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606-13. doi: 10.1046/j.1525-1497.2001.016009606.x

» https://doi.org/10.1046/j.1525-1497.2001.016009606.x

29- Ohrbach R, Fillingim RB, Mulkey F, Gonzalez Y, Gordon S, Gremillion H, et al. Clinical findings and pain symptoms as potential risk factors for chronic TMD: descriptive data and empirically identified domains from the OPPERA case-control study. J Pain. 2011;12(11 Suppl):T27–45. doi: 10.1016/j.jpain.2011.09.001

» https://doi.org/10.1016/j.jpain.2011.09.001

30- Sardá Junior J, Nicholas MK, Pereira IA, Pimenta CA, Asghari A, Cruz RM. Validação da escala de pensamentos catastróficos sobre dor. Acta Fisiatr. 2008;15(1):31–6. doi: 10.5935/0104-7795.20080001

» https://doi.org/10.5935/0104-7795.20080001

31- Jedynak B, Jaworska-Zaremba M, Grzechocińska B, Chmurska M, Janicka J, Kostrzewa-Janicka J. TMD in females with menstrual disorders. Int J Environ Res Public Health. 2021;18(14):7263. doi: 10.3390/ijerph18147263

» https://doi.org/10.3390/ijerph18147263

32- Stuenkel CA. Vasomotor and related menopause symptoms. Clin Obstet Gynecol. 2018;61(3):433–46. doi: 10.1097/GRF.0000000000000385

» https://doi.org/10.1097/GRF.0000000000000385

33- Shea AK, Sohel N, Gilsing A, Mayhew AJ, Griffith LE, Raina P. Depression, hormone therapy, and the menopausal transition among women aged 45 to 64 years using Canadian Longitudinal Study on Aging baseline data. Menopause. 2020;27(7):763–70. doi: 10.1097/GME.0000000000001540

» https://doi.org/10.1097/GME.0000000000001540

34- Utian WH, Woods NF. Impact of hormone therapy on quality of life after menopause. Menopause. 2013;20(10):1098–105. doi: 10.1097/GME.0b013e318298debe

» https://doi.org/10.1097/GME.0b013e318298debe

35- Dembe AE, Yao X. Why do female workers have a greater risk of long-term chronic disease compared to men? Occup Environ Med. 2018;75(Suppl 2):A530. doi: 10.1136/oemed-2018-ICOHabstracts.1503

» https://doi.org/10.1136/oemed-2018-ICOHabstracts.1503

36- Feng P, Lin L, Wang Y, Chen L, Min J, Xie Y, et al. Impacts of menopause hormone therapy on mood disorders among postmenopausal women. Climacteric. 2022;25(6):579–85. doi: 10.1080/13697137.2022.2026915

» https://doi.org/10.1080/13697137.2022.2026915

37- Gariepy G, Nitka D, Schmitz N. The association between obesity and anxiety disorders in the population: a systematic review and meta-analysis. Int J Obes (Lond). 2010;34(3):407–19. doi: 10.1038/ijo.2009.252

» https://doi.org/10.1038/ijo.2009.252

38- Kornetov N, Yarosh O, Sitnikova E. Depressive and anxiety disorders among women with obesity. Eur Psychiatry. 2021;64(Suppl 1):S339. doi: 10.1192/j.eurpsy.2021.909

» https://doi.org/10.1192/j.eurpsy.2021.909

39- Evans S, Dowding C, Olive L, Payne LA, Druitt M, Seidman LC, et al. Pain catastrophizing, but not mental health or social support, is associated with menstrual pain severity in women with dysmenorrhea: a cross-sectional survey. Psychol Health Med. 2022;27(6):1410–20. doi: 10.1080/13548506.2021.1948581

» https://doi.org/10.1080/13548506.2021.1948581

40- Del Prado R, García-Arrabé M, González-de-la-Flor Á, De La Plaza San Frutos M, Almazán Polo J, Guérineau F, et al. Exploration of the relationship between primary dysmenorrhea, pain perception, and menstruation-related quality of life in young women: a cross-sectional observational study. Front Glob Womens Health. 2025;6:1521276. doi: 10.3389/fgwh.2025.1521276

» https://doi.org/10.3389/fgwh.2025.1521276

Downloads

Published

2026-07-03

Issue

Section

Original Articles

How to Cite

Farias, L. N. G., Costa Neto, R. E. da, Pinheiro, M. A., & Cavalcanti, Y. W. (2026). Hormone therapy and psychosocial factors in menopausal women with painful TMD: a pilot cross-sectional study. Journal of Applied Oral Science, 34, e20250586. https://doi.org/10.1590/